)
Kerry S. Taylor has been practicing since 1998 in areas including Inter Partes Reviews, patent litigation, patent prosecution, strategic planning and counseling relating to infringement and licensing issues, and intellectual property due diligence studies.
Kerry is very active in our firm’s Inter Partes Review practice. He has led our firm’s efforts in Inter Partes Review in the life sciences, biotechnology and chemical industries, representing both Patent Owner and Petitioner in these proceedings. Kerry has also been involved in several Hatch-Waxman patent litigation proceedings. He also is active in patent prosecution and portfolio strategy development for various clients in the life sciences, including therapeutic oligonucleotide molecules and delivery, pharmaceuticals, and polymer chemistry.
Kerry received his doctorate degree in biochemistry and molecular biology from the University of Chicago where he worked in the field of structural biology, using primarily x-ray crystallographic techniques to study protein engineering and design. He was awarded the Lucille P. Markey award for his work. After receiving his doctorate degree, Kerry performed post-doctoral studies at the University of California at Berkeley directed to structural analysis of protein-ligand interactions.
Kerry joined the firm in 2005 and became a partner in 2010. Prior to joining the firm, he worked as an associate at Fish & Richardson PC. Before law school, Kerry worked as a patent agent at Campbell & Flores LLP.
Kerry S. Taylorは1998年以降、侵害およびライセンスの問題や知的財産のデューデリジェンス調査に関係する当事者系再審査、特許訴訟、特許審査、戦略的計画およびカウンセリングに従事してきました。
彼は当社の当事者系再審査業務に積極的に取り組んでいます。ライフサイエンス、バイオテクノロジー、化学産業の分野の当事者系再審査業務を指揮し、訴訟において特許所有者と申立人の両方の代理人を務めてきました。Hatch-Waxmanの特許訴訟にも関与しています。さらに、治療用オリゴヌクレオチド分子と投薬、医薬、ポリマー化学などのライフサイエンス産業のさまざまなクライアントの特許審査およびポートフォリオ戦略作成でも活躍しています。
シカゴ大学では構造生物学分野の研究を行い、生化学および分子生物学の博士号を取得しました。主にX線結晶技術を使用してタンパク質工学と設計について研究しました。その研究成果はLucille P. Markey賞を受賞しました。博士号を取得後、彼はカリフォルニア大学バークレー校でポスドク研究を行い、タンパク質リガンド相互作用の構造分析を指揮しました。
2005年に当社に入社した後、2010年に共同経営者となりました。前職では、Fish & Richardson PCでアソシエートとして勤務し、法律大学院に入学する前はCampbell & Flores LLPで特許出願代理人を務めました。
学歴
- カリフォルニア大学バークレー校法律大学院（法務博士、2003年）、Berkeley Center for Law and Technology修了証書、国際知的財産の分野でProsser賞、バイオテクノロジーと化学特許法の分野でAmerican Jurisprudence賞
- シカゴ大学（生物化学および分子生物学、1996年）、Lucille P. Markey賞、論文タイトル『Crystallographic analysis of de novo designed peptides and a thermophilic beta-glucosidase used in protein engineering』
- ホイートン大学（化学学士号、1988年）、優等で卒業
- Recognized as one of the "World's Leading Patent Professionals" for Litigation in the Patent 1000 guide by Intellectual Asset Management (IAM) magazine (2019-2022). In the 2019 guide, he was described as “[taking] charge of inter partes reviews in the life sciences space”.
- Recognized by The Legal 500 for Patent Prosecution in 2019
- Named a "Top Author" in JD Supra's 2018 "Readers' Choice Awards" for Patents Thought Leadership
- Named to the San Diego Daily Transcript's 2014 "Top Attorney" list for his IP Transactional work.
Kerry Taylor and Nathanael Luman co-authored, "What You Need to Know About the USPTO’s Proposed Rule Changes to PTAB Trials," The Intellectual Property Strategist (July 2020)
Kerry Taylor, Ted Cannon, Christy Lea, Michelle Armond co-authored, "Supreme Court Issues Two Important Decisions Affecting Inter Partes Review Patent Challenges," Knobbe Martens Firm Alert (Apr. 2018)
Kerry Taylor, Nathanael Luman, Carol Pitzel Cruz co-authored, "Three Statistics Every ANDA Filer Needs to Know About Orange Book Patent Trials At the USPTO," Knobbe Martens Firm Alert (March 2018)
Kerry Taylor, Scott Seeley co-authored, Federal Circuit's Treatment of Alleged APA Violations at the PTAB, Westlaw Journal Intellectual Property (January 2018)
Kerry Taylor, Brent Babcock co-authored, "The continuing CRISPR patent battle: the Broad Institute loses a key European patent " MedCity News (January 2018).
Kerry Taylor, Clayton Henson co-authored, "IPR Appeals in 2017: The Ouctomes Remand PTAB" Law360 (January 2018).
Kerry Taylor, Daniel Kamkar, Joel Broussard co-authored, "IPR Appeals in 2017: The Pendency And Success Rates," Law360 (January 2018).
Peter Law, Kerry Taylor, "Allergan and the Saint Regis Mowhawk Tribe Enter Patent Agreement to Defend Against IPR of RESTATIS® Patents" The Licensing Journal (December 2017).
Nathanael Luman, Kerry Taylor, "Can I Appeal my Inter Partes Review? The Federal Circuit Clarifies Article III Standing for Petitioners" National Institute for Trial Advocacy (September 2017).
Nathanael Luman, Kerry Taylor, "Five Techniques To Stop an IPR Before it Starts" Today's General Counsel (June 2017).
Nathanael Luman, Kerry Taylor, "AIA Trial Institution Rates Are Good News For Patent Owners" Law360 (May 2017).
Daniel Kamkar, Kerry Taylor, "IPR Appeals: Pendency And Success Rates At Fed. Circ." Law360 (February 2017).
Clayton Henson, Kerry Taylor, "IPR Appeals: Outcomes In Fed. Circ. Remands To PTAB" Law360 (February 2017).
K.S. Taylor, M.-Z. Lou, T.-M. Chin, N.C. Yang, R.M. Garavito, “A Novel, Multilayer Structure of a Helical Peptide” Protein Science 5:414-421 (1996).
K. S. Taylor, TrafFix Devices, Inc. v. Marketing Displays, Inc., 17 BERKELEY TECH. L.J. 205 (2002).
Eric Furman, Kerry Taylor, "Approaching Intellectual Property Protection for Biotechnology Companies in an Increasingly Competitive Market - The Over-Arching Issues You Need to Know" Aspatore Books (US) 2006.
E.S. Furman and K.S. Taylor, “Approaching IP protection for biotechs in increasingly competitive market.” San Diego Daily Transcript (October 19, 2006).
Speeches & Seminars
Presented on “Untangling the Inner Workings of IPRs for Biosimilars,” at the ACI 9th Annual Summit on Biosimilars in New York, NY (June 2018)
Presented on "Sovereign Immunity at the PTAB: Where do we stand?" at the 16th Advanced Summit on LIfe Sciences Patents, in New York, NY (February 2018).
Presented on "Post-Grant Review in Japan" at the Japan Patent Attorneys Association (JPAA) in San Diego, CA (February 2018).
Moderated panel discussion on "PTAB: A View From In-House" at the San Diego Intellectual Property meeting in San Diego, CA (November 2017).
Presented on "Inter Partes Review in the Life Sciences" at the BIOCOM Intellectual Property and Patent Law Committee Meeting in San Diego, CA (May 2016).
Presented on "Aftershocks of the AIA's Post Grant Proceedings: Its Advocates & Critics," at the Thomas Jefferson School of Law Intellectual Property Symposium in San Diego, CA (March 2016).
Presented on "The Evolving World of Biosimilars" at the University of Chicago Alumni Club of San Diego: Biotech Speaker Series (April 2015).
Presented on "Patent Trial and Appeal Board - Multi-Petition Challenges of a Patent" at the University of San Diego School of Law Fifth Annual Patent Law Conference in San Diego, CA (January 2015).
Presented on “Intellectual Property Seminar for Executives and IP Managers" in Tokyo, Japan (November 2013).
Presented on "Strategies for Taking Advantage of the America Invents Act, Resolving the Tension Between Patentable Subject Matter & Joint Infringement" in Tokyo, Japan (October 2012).
K.S. Taylor, D. Chung, R.M. Garavito, N. Pagratis, D. Demirjian, M. Casadaban, “Preliminary crystallographic studies on a b-galactosidase from Thermus acquaticus” American Crystallographic Association Annual Meeting, 1991.
K.S. Taylor, M.-Z. Lou, T.-M. Chin, N.C. Yang, R.M. Garavito, “Structure of a de novo designed helical peptide” American Crystallographic Association Annual Meeting, 1995.